Suppr超能文献

卵巢癌患者化疗后CA 125和TPS水平的预后意义

Prognostic significance of CA 125 and TPS levels after chemotherapy in ovarian cancer patients.

作者信息

van Dalen A, Favier J, Baumgartner L, Hasholzner U, de Bruijn H, Dobbler D, Dombi V H, Fink D, Giai M, McGing P, Harlozinska A, Kainz C, Markowska J, Molina R, Sturgeon C, Einarsson R

机构信息

Groene Hart Ziekenhuis, Gouda, The Netherlands.

出版信息

Anticancer Res. 1999 Jul-Aug;19(4A):2523-6.

Abstract

The analysis of survival data of patients with epithelial ovarian cancer proved that both CA 125 and TPS were good markers for clinical outcome prediction. Patients receiving chemotherapy were analyzed for 2-year overall survival (OS). Kaplan-Meier survival analysis showed highly significant differences in OS between patients with stage I+II (survival for 2 years 68%) and stage III+IV (survival for 2 years 33%; p = 0.0008). CA 125 levels above or below 35 kU/I and TPS levels above or below 80 U/l after 3 chemotherapy courses were not significantly correlated with OS in stage I+II patients (p = 0.06 respectively 0.07). However, in the subgroup of patients with stage III+IV the cut-off levels of CA 125 and TPS were excellent discriminators of OS: With CA 125 levels below the cut-off 52% of the patients survived, while with CA 125 levels above the cut-off only 13% survived (p < 0.0001). With TPS levels below the cut-off 49% of the patients survived, while with levels above the cut-off only 19% of the patients survived (p < 0.0001). In the subset of patients with CA 125 levels less than 35 kU/I after 3 chemotherapy courses (n = 50) analysis of their TPS levels allowed further discrimination of the prognostic significance. With TPS levels below the cut-off 63% of the patients survived, while 35% of the patients survived with TPS levels above the cut-off. The sum value of CA 125 and TPS cut-off values (115) as discriminator correlated even better with survival rate: With levels below this sum value 63% of the patients survived, while this was only 17% with sum values above the summed cut-off level (p = 0.0004). The extent to which the tumor was removed at operation also correlated with the 2 years survival rate. None of the patients with a staging laparotomy (n = 10) showed a 2-years survival. The difference in OS between patients with complete debulking and partial debulking was significant: OS 51% versus 23% (p = 0.027). Prognosis was not significantly correlated with histological type.

摘要

上皮性卵巢癌患者生存数据的分析证明,CA 125和TPS都是预测临床结局的良好标志物。对接受化疗的患者进行了2年总生存期(OS)分析。Kaplan-Meier生存分析显示,I+II期患者(2年生存率68%)和III+IV期患者(2年生存率33%;p = 0.0008)的OS存在高度显著差异。在I+II期患者中,3个化疗疗程后CA 125水平高于或低于35 kU/I以及TPS水平高于或低于80 U/l与OS均无显著相关性(分别为p = 0.06和0.07)。然而,在III+IV期患者亚组中,CA 125和TPS的临界值是OS的优秀判别指标:CA 125水平低于临界值的患者中52%存活,而CA 125水平高于临界值的患者中仅13%存活(p < 0.0001)。TPS水平低于临界值的患者中49%存活,而TPS水平高于临界值的患者中仅19%存活(p < 0.0001)。在3个化疗疗程后CA 125水平低于35 kU/I的患者亚组(n = 50)中,对其TPS水平的分析进一步区分了预后意义。TPS水平低于临界值的患者中63%存活,而TPS水平高于临界值的患者中35%存活。CA 125和TPS临界值的总和值(115)作为判别指标与生存率的相关性更好:总和值低于此值的患者中63%存活,而总和值高于临界值总和水平的患者中仅17%存活(p = 0.0004)。手术时肿瘤切除的程度也与2年生存率相关。进行分期剖腹手术的患者(n = 10)均无2年生存期。完全减瘤和部分减瘤患者的OS差异显著:OS分别为51%和23%(p = 0.027)。预后与组织学类型无显著相关性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验